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OBJECTIVES We undertook this study to determine whether human atrial fibrillation (AF) relates to
steeply sloped action potential duration restitution (APDR) kinetics and whether the spatial
nonuniformity of APDR promotes persistence of AF.
BACKGROUND A steeply sloped APDR curve is known to be an important determinant of the induction of
more complex action potential duration (APD) dynamics and fibrillation.
METHODS Patients with chronic atrial fibrillation (CAF) (n  18), paroxysmal atrial fibrillation (PAF)
(n  14) and normal control subjects (n  9) were studied. The monophasic action potential
duration at 90% repolarization (APD90) and the effective refractory period (ERP) were
measured at six sites in the right atrium. After AF was electrically converted, APDR was
assessed by delivering a single extrastimulus after a train of stimuli at a cycle length of 600 ms
(S1S2) at six different sites of the right atrium, as well as rapid pacing at cycle lengths that
induced APD alternans.
RESULTS The APD90 and ERP in patients with CAF were shorter than those in patients with PAF and
control subjects (p  0.05); however, the dispersions of APD90 and ERP in each group were
similar. The maximal slopes of APDR by S1S2 and rapid pacing in patients with CAF (1.2 
0.4 and 1.7  0.2) and PAF (1.1  0.4 and 1.3  0.4) were higher than those in control
subjects (0.5  0.3 and 0.8  0.2, respectively; p  0.01). The maximal slope obtained by
S1S2 did not differ from that obtained by rapid pacing in any group. The inter-regional
difference of the maximal slope in patients with CAF (1.6  0.4, p  0.05) was greater than
that in patients with PAF (1.2  0.3, p  NS vs. control) and control subjects (0.4  0.2).
CONCLUSIONS Atrial fibrillation was related to steeply sloped (1) APDR kinetics. The spatial dispersion
of APDR in patients with chronic AF was greater than that of patients with paroxysmal AF
and control subjects, indicating that the heterogeneity of APDR of the atrium plays an
important role in the persistence of AF. (J Am Coll Cardiol 2002;39:1329–36) © 2002 by
the American College of Cardiology Foundation
It is known that the dispersion of refractoriness is important
in the induction of re-entrant arrhythmias and causes
instability of re-entrant circuits (1–3). Recently, dynamic
heterogeneity arising from cardiac restitution properties has
been demonstrated to be a more important determinant
(4–8). When the slope of the action potential duration
restitution (APDR) curve, in which the action potential
duration (APD) is plotted against the preceding diastolic
interval (DI), is 1, the APD along the re-entrant wave
fronts will undergo beat-to-beat oscillations. If this oscilla-
tion in the APD grows large enough, localized conduction
block occurs, causing the wave break that is necessary for
fibrillation.
However, the relationship between the APDR properties
in the human atrium and its role in the mechanisms that
determine the stability of atrial fibrillation (AF) have not
been examined. Electrically induced and chronic atrial
fibrillation (CAF) both lead to electrical remodeling and
associated structural changes, which explain the progressive
nature of AF (9,10). In addition, nonuniform electrical
remodeling promotes increased atrial vulnerability to AF
and increased AF duration (11).
The present study was designed to test the hypothesis
that human AF relates to steeply sloped APDR kinetics,
and that these differ from those observed in patients with
CAF and paroxysmal atrial fibrillation (PAF). Furthermore,
the APDR characteristics are not uniform throughout the
atrium, which may be one of the important mechanisms
responsible for the persistence of AF.
METHODS
Study group. The study group consisted of 18 patients
with CAF (AF lasting 1 week) and 14 patients with PAF
(AF lasting 2 days), who were referred for cardioversion.
The mean duration of the AF episodes in patients with
CAF was 28  21 months (range 6 to 45 months). The
mean duration of symptoms in those with PAF was 10  9
months (range 1 to 22 months), and these patients experi-
enced, on average, two episodes (range 1 to 6 episodes) of
AF per month, lasting from 1 to over 48 h. Atrial fibrillation
was documented by 12-lead electrocardiography and/or
Holter monitoring. Patients with the following criteria were
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excluded: unstable angina or myocardial infarction, class III
or IV heart failure, the presence of left atrial thrombi,
significant valvular heart disease, reversible causes of AF
(e.g., electrolyte imbalance) and a contraindication to long-
term anticoagulant therapy.
The control group consisted of nine patients without
underlying structural heart disease, who underwent electro-
physiologic study for supraventricular or ventricular tachy-
cardia. None had experienced any spontaneous episodes of
AF.
Written, informed consent was obtained from all pa-
tients. The study protocol was approved by the institutional
Review Committee of the Korea University Hospital.
Electrical cardioversion and recording of monophasic
action potentials (MAPs). All patients were studied in the
postabsorptive, nonsedated state, and all antiarrhythmic
drugs were discontinued for at least five half-lives before the
beginning of the study. No patient was receiving amioda-
rone therapy. All patients with CAF received at least four
weeks of anticoagulation with warfarin, and the absence of
left atrial thrombi was confirmed by transesophageal echo-
cardiography before undergoing transthoracic direct-current
cardioversion. A 7F MAP recording catheter (Boston Sci-
entific EP Technologies, San Jose, California) was inserted
through the right femoral vein under fluoroscopic control
and positioned at six different sites (high lateral [HL], mid
lateral [ML], high posterior, mid posterior [MP], high
septal [HS] and mid septal) of the right atrium. The
position of the MAP electrode was adjusted until an
acceptable MAP signal was obtained. Electrocardiographic
leads II and V1 and the MAP output were displayed on an
oscilloscope and recorded at a paper speed of 100 mm/s
(Prucka Engineering, Inc., Houston, Texas). The MAP
electrogram was filtered from 0.05 to 500 Hz. After AF had
been converted to sinus rhythm, a 15-min wait was allowed
to enable short-term, rate-dependent changes in the APD.
Atrial pacing was performed using the MAP catheter at
twice the diastolic threshold. The APD at each site was
measured at 90% repolarization (APD90) during pacing at a
basic cycle length (BCL) of 600 ms.
Construction of the APDR curve. The restitution of
APD90 was determined using a single S2 delivered after
every eighth S1 at a BCL of 600 ms. The S1S2 interval was
started at 400 ms and was decreased in 20-ms steps until an
S1S2 of 300 ms was reached. Subsequently, it decreased
every 10 ms until atrial capture failed. It was then increased
by 8 ms and finally decreased in 2-ms steps until the atrial
effective refractory period (ERP) was reached. After each S2,
S1 pacing was interrupted for 5 s. The MAP signals were
analyzed with a custom-developed software algorithm,
which had been validated by previous studies (12,13). The
APDR curve was constructed by plotting the APD90 as S2
versus the preceding DI, which was obtained by subtracting
the APD90 of the eighth S1 from the S1S2 interval.
The restitution of APD90 was also determined using
rapid pacing at the high right atrium, which is the best site
to acquire a stable S1S2 recording. After 50 stimuli had been
delivered at an initial BCL of 400 ms, the BCL was
shortened in steps of 50 ms for BCLs250 ms, and in steps
of 10 ms for BCLs 250 ms until APD alternans or 2:1
block occurred. Fifty stimuli were given at each BCL.
Pacing was interrupted for 5 s when the BCL was changed.
The time course of restitution obtained by S1S2, and
rapid pacing was fit using the monoexponential equation:
y APD90  y0 A1 1  eDI/1)
where A1 is the free-fitting variable. With each A1 and 1 at
the correspondent DI, the slope was calculated using equation:
slope  A1/1[Exp (DI1/1)]
The slope of the shortest DI was defined as the maximal
slope of the APDR curve (4,14,15).
Spatial dispersion of ERP and MAP recordings. The
spatial dispersion of the ERP and APD90 during pacing at
a BCL of 600 ms was determined from the difference
between the maximal and minimal values recorded at six
different sites. The spatial dispersion of the maximal slope of
the APDR curve was calculated.
Statistical analysis. Results are presented as the mean
value  SD. The Student t test was used when appropriate.
Analysis of variance with the Newman-Keuls test was used
to perform multiple comparisons. A p value 0.05 was
considered significant.
RESULTS
Patient characteristics. In patients with CAF (mean age
53  6 years; 14 men and 4 women), the mean left
ventricular ejection fraction (LVEF) and left atrial diameter
were 62  12% and 43  4 mm, respectively. In patients
with PAF (mean age 51  7 years; 11 men and 3 women),
the mean LVEF and left atrial diameter were 65  8% and
40  3 mm, respectively. In the control subjects (mean age
50  15 years; 6 men and 3 women), the mean LVEF and
left atrial diameter were 67  4% and 38  3 mm,
Abbreviations and Acronyms
AF  atrial fibrillation
APD  action potential duration
APD90  action potential duration at 90% repolarization
APDR  action potential duration restitution
BCL  basic cycle length
CAF  chronic atrial fibrillation
DI  diastolic interval
ERP  effective refractory period
HL  high lateral
HS  high septal
LVEF  left ventricular ejection fraction
ML  mid lateral
MP  mid posterior
PAF  paroxysmal atrial fibrillation
MAP  monophasic action potential
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respectively. The patients with CAF had a significantly
larger left atrial diameter, as compared with patients with
PAF or control subjects. There was no significant difference
in the left atrial diameters of patients with PAF and control
subjects. Hypertension was present as an underlying disease
in 10 patients with CAF (56%) and in 3 patients with PAF
(21%). The energy requirement for cardioversion in patients
with CAF was significantly higher than that in patients with
PAF (p  0.01).
Differences between APD90 and ERP and their spatial
dispersions. The APD90 during pacing at a BCL of
600 ms in those with CAF (225.9  15.6 ms) was
significantly (p  0.05) shorter than that in patients with
PAF (250.3  34.6 ms) or control subjects (258.4  25.1
ms). The APD90 values at all of the recording sites, except
the HS, were shorter in patients with CAF than in those
with PAF or control subjects (p  0.05). The spatial
dispersion of APD90 values in patients with CAF (26.8 
22.2 ms) was no greater than that in patients with PAF
(30.1  18.9 ms) or control subjects (29.5  23.6 ms).
The ERP in patients with CAF (211.0  23.8 ms) was
shorter than that in patients with PAF (232.5 29.2 ms) or
control subjects (227.6  19.4 ms; p  0.05). The spatial
dispersions of the ERP in each group were similar (32.4 
30.3 ms in patients with CAF, 41.7  27.4 ms in patients
with PAF and 32.7  19.2 ms in control subjects).
Properties of APDR and spatial dispersion. Figure 1
shows a representative example of MAPs obtained from the
HL by a single S2 (left panel) and rapid pacing (right panel)
in a patient with CAF. As the DI decreased from 138 to
0 ms, the APD90 decreased from 240 to 158 ms, and then
reached the ERP with a coupling interval of 200 ms. In the
right panel of Figure 1, straight pacing with a cycle length
of both 220 and 190 ms resulted in APD alternans, and 2:1
block occurred with pacing at a cycle length of 180 ms.
Figure 2 shows an example of APDR by a single S2 in each
group. In the patients with PAF, as the DI decreased from
142 to 0 ms, the APD90 decreased from 256 to 156 ms and
resulted in a change in APD90 of 100 ms (middle panel),
which was similar to that of patients with CAF (left panel).
In the control subjects, the change in APD90 was 55 ms as
DI decreased from 147 to 0 ms (right panel).
Representative examples of APDR curves by S1S2 at the
same site of each group are shown in Figure 3. In patients
Figure 1. (A) Examples of monophasic action potentials recorded at the high lateral wall of the right atrium by S1S2 in patients with chronic atrial
fibrillation. A single extrastimulus (S2) was given at progressively shorter S1S2 intervals. As diastolic interval decreased from 138 to 0 ms, the action potential
duration (APD) at 90% repolarization decreased from 240 to 158 ms, and then reached the effective refractory period with a coupling interval of 200 ms.
(B) The right atrium was paced at progressively shorter S1S1 intervals until APD alternans and then 2:1 atrial capture failure occurred. Pacing with cycle
lengths of 220 and 190 ms resulted in APD and diastolic interval alternans.
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with CAF, the APD90 shortened with increasing prematu-
rity of the extrastimulus. As the DI decreased to 30 ms,
the APD90 shortened by 30 ms, and the maximal slope of
the curve was 1.6. In patients with PAF, the change in
APD90 was 31 ms, and the maximal slope was 1.4. In
contrast, in the control subjects, the decrease in the APD90
with increasing prematurity was small, which resulted in a
flat APDR curve. As the DI decreased to 30 ms, the
change in APD90 was 23 ms, and the maximal slope was
0.8. Figure 4 shows a representative example of APDR by
S1S2 and rapid pacing in each patient. The slopes of the
APDR curve by rapid pacing in patients with CAF (1.7 
Figure 2. Monophasic action potentials recorded at the high lateral wall of the atrium by S1S2 in each group (patients with chronic atrial fibrillation [CAF]
in the left panel; patients with paroxysmal atrial fibrillation [PAF] in the middle panel; and control subjects in the right panel). In the patients with CAF
and PAF, as the diastolic interval progressively decreased to 0 ms, the changes in action potential duration at 90% repolarization (APD90) were 110 and
100 ms, respectively. In the control subjects, the change in APD90 was 55 ms as the diastolic interval decreased from 147 to 0 ms.
Figure 3. The action potential duration restitution (APDR) curves by S1S2 in each group (patients with chronic atrial fibrillation [CAF] in the left panel;
patients with paroxysmal atrial fibrillation [PAF] in the middle panel; and control subjects in the right panel). In patients with CAF, action potential
duration at 90% repolarization (APD90) shortening became 30 ms as the diastolic interval (DI) decreased to 30 ms (APD90) and the maximal slope
(Slopemax) was 1.6. In patients with PAF, the change in APD90 was 31 ms, and the maximal slope was 1.4. In contrast, the decrease in APD90 with
increasing prematurity was small in the control group, which resulted in a flat APDR curve (Slopemax  0.8).
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0.2) and PAF (1.3  0.4) were steeper that those obtained
by S1S2, but there was no statistical significance. Overall,
the mean slope of the APDR curve by S1S2 both in patients
with CAF (1.4  0.3) and PAF (1.1  0.4) was signifi-
cantly greater than that of the control subjects (0.5  0.3,
p 0.01). No significant difference was evident between the
CAF and PAF groups.
The APDR curves obtained at four different sites (HL,
HS, MP and ML) are shown in Figure 5. Shortening of the
APD90 with a decreasing DI in patients with CAF was
greater in the HL and ML regions than in the MP and HS
regions, resulting in a spatial dispersion of the maximal
slope of 2.1 (lower panel), which was greater than that in
patients with PAF (1.7) or control subjects (0.8). Mean
spatial dispersion of the maximal slope in patients with
CAF (1.6 0.4) was greater than that in patients with PAF
(1.2  0.3) or control subjects (0.4  0.2; p  0.05). These
observations indicate that the spatial dispersion of APDR in
patients with CAF may form the substrate for the persis-
tence of AF.
Validation of APDR by two independent observers. The
APDR curves were validated by two independent observers
in both the patients with AF and control subjects. There
was a measurement error of approximately 10 ms in the
APDR curve, and the regional differences in the slope were
minimal (0.02).
DISCUSSION
Changes in atrial refractoriness of AF. Shortening of the
atrial ERP (16–18) and increased dispersion of ERP
(11,18–20) have been described in patients with AF. Evi-
Figure 4. Representative examples of action potential duration restitution (APDR) by S1S2 (left panels) and rapid pacing (right panels). The slope of
APDR by rapid pacing was slightly steeper than that of restitution by S1S2 in each patient. APD90  action potential duration at 90% repolarization;
CAF  chronic atrial fibrillation; DI  diastolic interval; PAF  paroxysmal atrial fibrillation; Slopemax  maximal slope.
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dence for AF-induced remodeling in the human atrium has
been presented (21–23). These studies demonstrated that
the monophasic APD90 or ERP in patients who had
cardioversion of CAF was significantly shorter than that in
control subjects. Furthermore, abnormal adaptation of the
ERPs in relation to a change in the cycle length has been
observed (18,24,25). Fareh et al. (11) reported that an
increase in the regional heterogeneity of the ERP in the
different parts of the atrium played an important role in
enhancing vulnerability to AF, whereas the ERP, per se,
was not a significant determinant. The ionic mechanisms
responsible for the alterations in atrial ERP have been
demonstrated in a canine model of AF (26), but regional
variations in the ERP of patients with AF, as well as their
mechanisms, are still unclear.
The present study has shown that the dispersion of atrial
refractoriness in patients with CAF was not greater than
that in patients with PAF or control subjects. This finding
is in agreement with the results of previous studies (11,24)
and may be due to a general shortening of the ERP in
patients with CAF.
Electrical restitution properties in the atrium. A wave
break is known to be one of the important mechanisms
responsible for the maintenance of fibrillation and is asso-
ciated with steeply sloped (1) restitution kinetics (4,27). In
contrast, if the slope is 1, perturbations in the APD and DI
are damped, rather than amplified, which resists a wave break.
The present study has shown that the maximal slope of
the APDR curve is significantly steeper in patients with
CAF and PAF than in control subjects. These results are
inconsistent with the results of a study by Hara et al. (14),
who found that the slope of the APDR curves in canine
atria with sustained and nonsustained AF was smaller (1)
than that of normal atria. These conflicting results can be
explained: First, Hara et al. (14) recorded action potentials
at only two sites—Bachmann’s bundle and the trabeculae.
In this study, the slope of the APDR curve was found to
show inter-regional variation, indicating that the APDR
obtained at a single site or two sites does not represent the
whole atria. Second, there are important differences between
the pacing model of the fibrillating canine atria (pacing for
5 weeks) and that of the chronically fibrillating human atria.
In the pacing model of AF, there are no differences in the
steady-state action potentials or APDR between sustained
and nonsustained AF, suggesting that it is less likely that
alteration of the cellular electrophysiologic mechanisms
with pacing is associated with chronic remodeling of the
cellular structure.
Figure 5. (A, top row) The action potential duration restitution (APDR) curves. (B, bottom row) Corresponding nonlinear slopes plotted as a function
of DI obtained at four sites of the right atrium (high lateral [HL], high septal [HS], mid posterior [MP] and mid lateral [ML]). Shortening of action
potential duration at 90% repolarization (APD90) with decreasing diastolic interval (DI) in patients with chronic atrial fibrillation (CAF) (left panels) was
greater at the HL and ML sites than at the MP and HS sites, resulting in a change in the maximal slope (Slopemax) of 2.1. In patients with paroxysmal
atrial fibrillation (PAF) (middle panels), Slopemax was 1.7. Regional differences of the APDR curve were not evident in the control subjects (right panels),
and resulted in a Slopemax of 0.8.
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We suggest that a steep slope of the APDR curve in
patients with AF may be associated with frequent occur-
rence of a wave break, resulting in the initiation or perpet-
uation of fibrillation, or both. In contrast, in the ring model
of atrial re-entry, Frame and Simson (28) described that a
steep slope (1) favored large cycle length oscillations and
termination of re-entry, whereas a flat slope decreased
oscillations and improved the stability of re-entry. If stable
re-entry is an important mechanism by which fibrillation
perpetuates, a chronically fibrillating atrium may show a flat
slope, as shown in the study by Hara et al. (14). However,
it remains to be determined whether stable re-entry plays an
important role in the maintenance of fibrillation, or whether
the fibrillation is terminated if this re-entry is halted.
Restitution of the APD during pacing at a cycle length of
600 ms might not account for APD dynamics during AF,
because it is difficult to extrapolate the slope of the restitu-
tion curve from the lower rates to the ultra-high rates
present during AF. It is demonstrated that dynamic pacing
(pacing at progressively faster rates until 1:1 capture fails) is
relevant to fibrillation and is superior to the S1S2 method in
terms of estimating restitution (15). The time course of
changes in APD after a sudden, sustained change in the
cycle length is “rate adapted,” rather than “restituted” (29).
During APD alternans induced by rapid pacing, a short DI
sequence generates a short APD sequence, which is also
linked to the slope of the restitution relationship. In this
study, the maximal slope of the restitution curve by S1S2 was
lower than that obtained using the dynamic protocol, but there
was no statistical difference. Therefore, our findings indicate
that APD dynamics in patients with AF can be explained by a
single extrastimulus in the restitution relationship, as well as by
dynamic pacing that induced APD alternans.
Heterogeneity of restitution in the atrium. Laurita et al.
(30) reported that restitution properties vary when measured
at hundreds of sites across the ventricle. This spatial
heterogeneity creates critical gradients or a dispersion of
repolarization and results in the modulation of the electro-
physiologic substrate for re-entrant arrhythmias and vulner-
ability to fibrillation.
In the present study, inter-regional differences in the
APDR curves were greater in patients with CAF than in
those with PAF or control subjects. Thus, spatial dispersion
of APDR may relate to the perpetuation of AF. However,
the electrophysiologic basis of the nonuniform APDR
properties remains unclear and requires further study.
Study limitations. First, the limitations of fluoroscopic
guidance for electrode placement, as well as the difficulties
of electrode manipulation, did not allow us to record the
numerous MAPs from a precisely defined region of the
endocardial surface. Second, in patients with CAF, the total
energy required for cardioversion was higher than that in
patients with PAF. We cannot exclude the possibility that
the electrophysiologic changes might be related to the
amount of direct current energy. Third, the episodes of AF
in the PAF group lasted from 1 to 48 h, and this wide range
of AF persistence may have affected the results. Fourth, the
number of patients in each group was too limited to allow
our findings to be uncritically extrapolated to all patients
with AF. Finally, whether normalization of the spatial
heterogeneity of APDR in the atrium can have an antifi-
brillatory effect, and thus prevent or terminate AF, remains
unclear.
Conclusions. The slope of APDR in patients with CAF
and PAF is steeper than that of control subjects. The
APDR in patients with CAF is spatially nonuniform, and
this contributes to the perpetuation of AF.
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